Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

25.18USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$25.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
150,180
52-wk High
$41.75
52-wk Low
$24.74

Select another date:

Mon, Nov 12 2018

Photo

Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million (76 million pounds) to raise its stake in Aimmune Therapeutics Inc , the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

UPDATE 2-Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

BRIEF-Aimmune Therapeutics Announces Additional Equity Investment By Nestlé Health Science

* AIMMUNE THERAPEUTICS ANNOUNCES ADDITIONAL EQUITY INVESTMENT BY NESTLÉ HEALTH SCIENCE

Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science unit of Nestle SA would pay $98 million to increase its stake in Aimmune Therapeutics Inc, the drug developer for food allergies said on Monday.

Select another date: